In metastatic melanoma, a high number of infused TILs, a high proportion of CD8+ T cells and TIL reactivity towards autologous tumor cell lines in vitro have previously been associated with improved clinical outcome18,28. The gene discussed is CD8A; the disease is metastatic melanoma.